Sentences with phrase «dollar revenue growth»

Business Analyst Banking Sector Solving Complex Business Problems and Fueling Multimillion - Dollar Revenue Growth

Marketing Leader with proven track record in a Fortune 500 company and one of the most highly trusted brands in the world; achieved successive years of multi-million dollar revenue growth worldwide.

Summary Dynamic, results - driven sales strategist with a 15 + year record of achievement and demonstrated success driving multimillion - dollar revenue growth in highly competitive markets.

Naturally, we worked together to extract some impressive numbers (4 years in President's Club, leadership for a 10 - person team, multimillion - dollar revenue growth, etc.).

Dynamic, results - driven sales strategist with 14 + year record of achievement and demonstrated success driving multimillion - dollar revenue growth while providing visionary sales leadership in highly competitive markets.

Leverages subject matter expertise and exemplary leadership to deliver multimillion - dollar revenue growth, operational excellence, and profitable return - on - investment.

It is hard to post US dollar revenue growth when half of your revenues comes from offshore and your currency gained 12 % against other currencies during the same year.

It is hard to post US dollar revenue growth when half of your revenues comes from offshore and your currency gained 12 % against other currencies during the same year.

Not exact matches

In 2015, revenue for the 500 largest global corporations dropped 11.5 % to $ 27.6 trillion, owing to falling oil prices and in part by the surge in value of the U.S. dollar, which has stalled economic growth worldwide.

Revenue growth has slowed as many companies sink more resources into developing the next blockbuster drug; what's more, the «patent cliff» for the last round of megabillion - dollar drugs — when generics firms typically see a sales spurt — happened a few years ago.

Their plan to balance the budget involved 18 billion dollars in spending cuts, along with $ 16 billion in additional revenue gained from economic growth.

Estee Lauder has also seen tremendous growth in its overseas markets, though the strong U.S. dollar has weighed on that revenue.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

The top three US equity benchmarks closed mixed with the Dow slipping as IBM plunged 7.5 per cent after it reported narrower profit margins in the first quarter and no revenue growth unless one factors in help from a weak US dollar.

The company reported a 7.2 % growth in dollar revenue at an operating margin of 24.3 % and clocked a net revenue of $ 10.94 billion in fiscal 2018.

In addition, we are forecasting Stuart Weitzman brand sales to be in the area of $ 335 million on a dollar basis for fiscal 2016, an increase of about 10 % from FY 2015 driving Coach, Inc. consolidated revenue growth to high - single digits and adding about $ 0.09 to earnings per diluted share excluding charges associated with financing, short - term purchase accounting adjustments, contingent payments and integration costs.

Cryan reduced risk and settled billion - dollar legacy misconduct cases, but failed to restore revenue growth despite raising fresh capital.

The dollar revenue of interest earnings is rising, this due to the growth of bank balance sheets, but there is no corresponding expansion of income as a percentage of earning assets.

The company has been expanding its international sales and growing its revenue in local currency terms, but because of the recent strength of the dollar that growth has not been reflected in its top line.

Its growth continued into 2017, when revenue and adjusted net income grew by 16 % and 18 %, respectively, driven largely by 10 % growth in its gross dollar volume (the total dollar amount of transactions and cash disbursements made with Mastercard - branded cards).

In light of the benefit growth under current law — which greatly outpaces the growth in available revenue — it is far from clear that further net increases are a wise use of scarce dollars, particularly since broad - based expansions can be quite costly.

At the centre of Amatil X is AX Ventures, a multimillion dollar corporate venturing program, set up to invest in future revenue growth opportunities outside of Amatil's core - and beyond innovation in beverages which sits within the core business.

The march toward a half - billion dollars in revenue is occurring through a mix of organic growth and acquisitions.

The report from state Comptroller Tom DiNapoli does highlight a vastly improved financial picture for the state in recent years, though «the state may face increasing budgetary challenges in coming years as revenue growth is expected to slow and billions of dollars in settlement money are spent.»

Overall revenue is down 6 % over the prior quarter, but due to lower operating costs and continued growth from JDate, Spark still saw an increase in net income of $ 1.6 million dollars.

Revenue growth has been outpaced by rising expenditures associated with cities» trillion - dollar - plus retirement benefit liabilities.

However, the majority of growth in Medicaid spending results from increased federal dollars passed through to state budgets and not increased spending from state revenue sources.7

While low rates and sluggish wage growth have allowed profit margins to remain at record levels, large U.S. companies continue to struggle with the competitive headwind caused by a stronger dollar, which has hurt revenues and estimates of third quarter earnings.

[There will be a meaningful currency hit next year from a stronger dollar (UDG will report in dollars from now on), but I expect this to be broadly offset by underlying revenue growth & recent acquisitions].

Companies, especially in emerging economies, borrowing in US dollars, typically at quite low rates, and forgetting a bit about future currency risk or future revenue and growth risk on their side.

Our operations will be self - supporting based on traditional sources of revenue and our growth and expansion based on transformational, philanthropic dollars.

That growth has resulted in renewable energy businesses investing close to $ 10 billion dollars in the state, support over 5,000 well - paying jobs, and contributes to state and local revenue by paying over $ 150 million.

The combination of robust growth at UK practices and the relative strength of sterling against the dollar during the last financial year saw many London - based firms rise up the revenue rankings.

As we add data center capacity and support personnel in advance of anticipated growth, our delivery costs will increase in absolute dollars and if such anticipated revenue growth does not occur, our delivery costs as a percentage of revenue will be adversely affected.

Meanwhile, the sales revenue of HUAWEI Consumer Business Group (BG) in 2014 was 12.1 billion US dollars, breaking the US$ 10 billion mark for the first time, with year - on - year growth of 32.6 %.

That projection accounts for investors» concerns around lower revenue growth after the company moved to slow down ad load and thereby, inventory growth, the lack of consumer traction of late, and the weaker dollar.

To value Spotify's existing subscribers, I started with the base revenue per subscriber and content costs in 2017, made assumptions about growth in each item and used a renewal rate of 94.5 %, based again upon 2017 numbers (all in US dollar terms):

To increase value, measure achievements by sharing quantifiable figures as much as possible (i.e: percentage of revenue growth, sales in dollars, number of delivery deadlines achieved, team sizes, total project finalized).

«For over 20 years I've been steering new vision to capture record - breaking double - digit revenue, market share, and profit growth for consumer goods startups and multi-billion dollar global brands.»

The bullet points list accomplishments where sales increased by billions of dollars, longer term alliances were built and revenue growth exceeded 200 %.

My expertise lies in devising and implementing effective business development strategies, driving start - up sales teams, and securing multimillion - dollar contracts to accelerate sales and revenue growth.

Identify your top 6 - 10 actions that resulted in multi-million dollar cost savings or high percentage revenue growth.

Tags for this Online Resume: Logistics, Payroll, Benefits, Budgeting, Cash Flow, Human Resources, Insurance, Pricing, Recruiting, Sourcing, P&L LEADERSHIP, STRATEGIC PLANNING, PROFITABILITY OPTIMIZATION, MULTIMILLION - DOLLAR BUDGETING, TRAINING, COACHING & MENTORSHIP, CONTINUAL PROCESS IMPROVEMENT, PERFORMANCE MONITORING, RELATIONSHIP DEVELOPMENT, MULTISITE FACILITIES MANAGEMENT, PROCESS & POLICY IMPLEMENTATION, RESPONSIVE EMPLOYEE RELATIONS, HR / RECRUITING, REGULATORY COMPLIANCE, CONTRACT NEGOTIATIONS, MANUFACTURING & QUALITY MANAGEMENT, SUPPLY CHAIN OVERSIGHT, Productivity & Efficiency Gains, Turnaround Expertise, Process Improvement, Time & Resource Optimization, Expedited Growth, CHANGE MANAGEMENT, ISO - AS 9100, ISO 13485, ISO / TS 16949 & ISO 9001, Six Sigma, 5S methodology, TPS, lean manufacturing, visual management, performance measurement, Poka - Yoke, QCO, TPM, QCPC, Kaizen & Kanban., Private Equity, Portfolio Company, EBITDA Growth, Revenue Acceleration, Margin Enhancement, Multiple Expansion, Deal Origination, Topgrading, New Channels, New Markets, International Expansion, CEO, Global Footprint, CXO, COO, Turnarounds, Exit Strategies, President, Vice President, Director, Director of Manufacturing, Director of Operations, Vice President of Manufacturing, Vice President of Operations

HOSPITALITY / FOOD & BEVERAGE EXECUTIVE Hotel, Food & Beverage & Resort Operations • Strategic Planning, Growth & Market Opportunities Track record of contributions to significant revenue and profit growth Innovative, resourceful, and results - producing hospitality executive with 20 + years of experience managing multimillion dollar conglomerate hotel operations for Fortune 500 and other corporaGrowth & Market Opportunities Track record of contributions to significant revenue and profit growth Innovative, resourceful, and results - producing hospitality executive with 20 + years of experience managing multimillion dollar conglomerate hotel operations for Fortune 500 and other corporagrowth Innovative, resourceful, and results - producing hospitality executive with 20 + years of experience managing multimillion dollar conglomerate hotel operations for Fortune 500 and other corporations.

Experienced, knowledgeable and innovative software Sales Account Management leader with a proven track record in managing multimillion - dollar sales portfolio and aggressively driving market growth while increasing revenue.

I offer an impressive track record of generating multi million - dollar sales growth and expanding revenue streams by leading teams to maximize market share, sales channels, and key accounts.

Delivered multimillion - dollar annual revenue growth for the past decade and earned # 1 rankings and numerous awards throughout career, including:

Result - driven executive (18 + years, 35 Clinical Trail Designs and recruiting more than 3000 patients) with expertise commissioning and leading technology - based, Multi-million dollars revenue and growth initiatives ground solidly on business and economic value.

Results driven IT / Security executive with expertise envisioning and leading technology - based multi-million dollar revenue and growth initiatives grounded solidly on business and economic value.

Professional Experience TravelFocus (City, ST) 10/2008 — Present Director of Client Relations & Marketing • Design and implement comprehensive marking campaigns and all collateral materials for a multimillion dollar travel agency • Oversee account management team, corporate accounts, relationship development, communications, and contract negotiation • Develop and implement sales training program, sales strategies, revenue targets and departmental budgets • Create TravelFocus Hotel Program, Sales Force, and Concur Travel resulting in significant revenue gains • Deliver all TravelFocus and client contractual, P&L, and growth objectives • Provide exceptional customer service resulting in client satisfaction, loyalty, and referrals